RadioMedix and Curium announce FDA approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

7 September 2020 - RadioMedix and its commercial partner Curium announced today that Detectnet (copper Cu 64 dotatate injection) was approved ...

Read more →

Roche receives FDA approval for first HIV-1/HIV-2 Qualitative Test on the cobas 6800/8800 Systems in the fight against HIV/AIDS

1 September 2020 - Detects, confirms and differentiates HIV-1 and HIV-2 infections providing clinicians with critical diagnostic data for personalised management ...

Read more →

A quick virus test? Sure, if you can afford it.

31 August 2020 - Standard tests in New York City can take days or weeks. Wealthier people are turning to concierge ...

Read more →

FDA approves Foundation Medicine's FoundationOne Liquid CDx, a comprehensive pan-tumour liquid biopsy test with multiple companion diagnostic indications for patients with advanced cancer

26 August 2020 - FDA approval includes companion diagnostic claims for Rubraca (rucaparib), the first PARP inhibitor approved in a prostate ...

Read more →

Medicare expands coverage for BRACAnalysis CDx in prostate cancer

31 July 2020 - Myriad Genetics announced today that Medicare has expanded coverage for BRACAnalysis CDx for men with prostate cancer ...

Read more →

Alzheimer's: 'promising' blood test for early stage of disease

29 July 2020 - A blood test could spot Alzheimer's disease at the earliest stage and years before symptoms appear, ...

Read more →

FDA approves Roche’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapy

29 July 2020 - Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time. ...

Read more →

Zionexa USA and PETNET Solutions announce FDA approval of Cerianna (Fluoroestradiol F 18)

27 May 2020 - Zionexa USA and PETNET Solutions have announced that the FDA has approved Cerianna (fluoroestradiol F 18) injection ...

Read more →

FDA approves first drug to image tau pathology in patients being evaluated for Alzheimer’s disease

28 May 2020 - Today, the U.S. FDA approved Tauvid (flortaucipir F18) for intravenous injection, the first drug used to help ...

Read more →

Advanced Accelerator Applications announces Health Canada approval of Netspot diagnostic imaging agent kit to detect neuroendocrine tumours

7 April 2020 - Netspot is the first and only kit for the preparation of gallium (68 Ga) oxodotreotide injection for ...

Read more →

RadioMedix and Curium Announce copper Cu 64 dotatate injection was granted priority review by the U.S. FDA

11 March 2020 - RadioMedix and its commercial partner Curium announced the U.S. FDA has granted copper Cu 64 dotatate injection ...

Read more →

FDA authorises marketing of the first genetic test to aid in the diagnosis of Fragile X syndrome

21 February 2020 - The U.S. Food and Drug Administration today authorised marketing of the first test to detect a genetic ...

Read more →

FDA takes significant step in coronavirus response efforts, issues emergency use authorisation for the first 2019 novel coronavirus diagnostic

4 February 2020 - Critical milestone reached in response to this outbreak. ...

Read more →

Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime

27 January 2020 - Jubilant Radiopharma announced today that the company received approval from Health Canada for Drax Exametazine (Kit ...

Read more →

RadioMedix and Curium announce FDA filing of copper Cu 64 dotatate injection new drug application

7 January 2020 - RadioMedix and its commercial partner Curium announced today that the new drug application for copper Cu 64 ...

Read more →